APIXABAN 2.5 MG TABLETS

Apixaban 2.5 mg Tablets provide gentle, reliable anticoagulation support for individuals who require ongoing prevention of blood clots as directed by their healthcare professional. Apixaban is a direct oral anticoagulant (DOAC) that works by selectively inhibiting Factor Xa, a key component in the blood clotting process. This helps slow down clot formation and supports healthier, smoother blood flow throughout the body.

The 2.5 mg strength is often prescribed as a maintenance or reduced dose for individuals with specific medical considerations, such as age, weight, or kidney-related factors. It is commonly used for long-term prevention of clot-related events in select individuals with non-valvular atrial fibrillation or as an extended therapy option following certain clotting conditions. With predictable twice-daily dosing, Apixaban 2.5 mg offers consistent anticoagulation without the need for routine blood monitoring.

Manufactured under strict pharmaceutical guidelines, Apixaban 2.5 mg Tablets ensure dependable potency, purity, and safety. Their easy-to-swallow design supports daily comfort and adherence, making them a trusted part of medically supervised anticoagulation therapy.

Key Benefits

Helps Reduce the Risk of Blood Clots:
Supports prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and other clot-related risks.

Promotes Smooth and Healthy Circulation:
Inhibits Factor Xa to slow clot formation and maintain more consistent blood flow.

Suitable for Long-Term Maintenance:
Low-dose formulation ideal for ongoing anticoagulation needs under medical guidance.

Key Features

Reduced 2.5 mg Strength:
Designed for individuals requiring gentle, steady anticoagulation support as prescribed.

Pharmaceutical-Grade Quality:
Manufactured with strict quality controls to ensure purity, potency, and consistent performance.

Twice-Daily Administration:
Formulated for predictable absorption and convenient daily use to support treatment adherence.